This is a Validated Antibody Database (VAD) review about dog VIM, based on 170 published articles (read how Labome selects the articles), using VIM antibody in all methods. It is aimed to help Labome visitors find the most suited VIM antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
VIM synonym: vimentin

Knockout validation
Sigma-Aldrich
mouse monoclonal (V9)
  • western blot knockout validation; human; 1:100; loading ...; fig 4a
  • immunoprecipitation; human; loading ...; fig 1a
  • immunocytochemistry; human; 1:100; loading ...; fig 1b
Sigma-Aldrich VIM antibody (Sigma, V6389) was used in western blot knockout validation on human samples at 1:100 (fig 4a), in immunoprecipitation on human samples (fig 1a) and in immunocytochemistry on human samples at 1:100 (fig 1b). Biochem Biophys Res Commun (2018) ncbi
Abcam
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:500; loading ...; fig s4i
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on human samples at 1:500 (fig s4i). Science (2018) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - frozen section; domestic ferret; loading ...
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry - frozen section on domestic ferret samples . Nature (2018) ncbi
mouse monoclonal (RV202)
  • western blot; human; loading ...; fig 3c
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples (fig 3c). J Exp Clin Cancer Res (2018) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:1000; loading ...; fig 2b
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:1000 (fig 2b). Mol Med Rep (2017) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry; human; loading ...; fig 6i
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry on human samples (fig 6i). J Biol Chem (2017) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; mouse; 1:50; loading ...; fig 1f
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on mouse samples at 1:50 (fig 1f). Am J Transl Res (2017) ncbi
mouse monoclonal (RV202)
  • western blot; human; loading ...; fig 1h
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples (fig 1h). Biochem Biophys Res Commun (2016) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:1000; loading ...; fig s2a
In order to elucidate how CELF1 governs the epithelial-to-mesenchymal transition, Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:1000 (fig s2a). Nat Commun (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2a
In order to test if metastasis can be reduced by targeting cancer-associated fibroblasts with Pirfenidone, Abcam VIM antibody (Abcam, ab8069) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry; human; fig 3A
In order to study the human corneal endothelial cell via a 3D map, Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry on human samples (fig 3A). Sci Rep (2016) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - paraffin section; rat; 1:50; fig 2
  • western blot; rat; 1:1000; fig 2
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry - paraffin section on rat samples at 1:50 (fig 2) and in western blot on rat samples at 1:1000 (fig 2). Physiol Rep (2016) ncbi
mouse monoclonal (VI-10)
  • immunocytochemistry; human; 1:100; fig s15
Abcam VIM antibody (Abcam, ab20346) was used in immunocytochemistry on human samples at 1:100 (fig s15). Nat Commun (2016) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; rat; 1:500; fig 1
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on rat samples at 1:500 (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (RV203)
  • immunohistochemistry - paraffin section; rat; 1:100; fig 6
Abcam VIM antibody (Abcam, ab8979) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 6). PLoS ONE (2016) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; rat; 1:500; fig 5
  • western blot; rat; fig s5
In order to elucidate an increase of apoptosis and disruption of cytoskeleton organization of rat neural crest stem cells via upregulating CXCR4 expression and RhoA-ROCK1-p38 MAPK-p53 signaling due to simulated microgravity, Abcam VIM antibody (Abcam, RV202) was used in immunocytochemistry on rat samples at 1:500 (fig 5) and in western blot on rat samples (fig s5). Stem Cells Dev (2016) ncbi
mouse monoclonal (RV202)
  • western blot; water buffalo; 1:3000; fig 5
Abcam VIM antibody (Abcam, ab8978) was used in western blot on water buffalo samples at 1:3000 (fig 5). Int J Mol Sci (2016) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 5c
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry - paraffin section on rat samples (fig 5c). Oncotarget (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rat; 5 ug/ml; fig 4
Abcam VIM antibody (abcam, ab8069) was used in immunohistochemistry on rat samples at 5 ug/ml (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (V9)
  • immunoprecipitation; human; fig 4
  • western blot; human; 1:10,000; fig 4
Abcam VIM antibody (Abcam, ab8069) was used in immunoprecipitation on human samples (fig 4) and in western blot on human samples at 1:10,000 (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; mouse; loading ...; fig 4g
  • western blot; mouse; loading ...; fig 4f
  • immunocytochemistry; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 4a
Abcam VIM antibody (Abcam, Ab8978) was used in immunocytochemistry on mouse samples (fig 4g), in western blot on mouse samples (fig 4f), in immunocytochemistry on human samples (fig 4b) and in western blot on human samples (fig 4a). Nat Commun (2016) ncbi
mouse monoclonal (VI-10)
  • immunocytochemistry; human; 1:200; fig 5
Abcam VIM antibody (abcam, ab20346) was used in immunocytochemistry on human samples at 1:200 (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig 2b
  • western blot; human; loading ...; fig 2c
In order to explore the link between HDAC1 and progesterone receptor A in myometrium samples, Abcam VIM antibody (Abcam, ab8069) was used in immunocytochemistry on human samples (fig 2b) and in western blot on human samples (fig 2c). Reprod Sci (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; fig 2
Abcam VIM antibody (Abcam, ab8069) was used in immunohistochemistry on human samples (fig 2). Int Braz J Urol (2015) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:500; fig 2
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:500 (fig 2). Mol Med Rep (2016) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:1000; loading ...; fig 5C
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:1000 (fig 5C). Mol Oncol (2016) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1c
Abcam VIM antibody (Abcam, Ab8978) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1c). PLoS ONE (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:200
In order to study the insulin/IGF1 signaling pathway in human astrocytes, Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on human samples at 1:200. Mol Brain (2015) ncbi
mouse monoclonal (RV203)
  • immunocytochemistry; human; loading ...; fig 2b
  • western blot; human; 1:100; loading ...; fig s4c
Abcam VIM antibody (AbCam, ab8979) was used in immunocytochemistry on human samples (fig 2b) and in western blot on human samples at 1:100 (fig s4c). Cell Death Dis (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig 3
Abcam VIM antibody (Abcam, ab8069) was used in immunocytochemistry on human samples (fig 3). Mol Cell Proteomics (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:25
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on human samples at 1:25. Biomaterials (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:20; fig 4
In order to discuss methods to generate and study neural crest cells, Abcam VIM antibody (Abcam, Ab8978) was used in immunocytochemistry on human samples at 1:20 (fig 4). Cell J (2015) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:1000; fig 2
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 2e
Abcam VIM antibody (Abcam, ab8069) was used in western blot on human samples (fig 2e). PLoS ONE (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:100; loading ...; fig 4d
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on human samples at 1:100 (fig 4d). Mol Med Rep (2015) ncbi
mouse monoclonal (RV202)
  • western blot; human; fig 3
Abcam VIM antibody (Abcam, AB8978) was used in western blot on human samples (fig 3). Sci Rep (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human
In order to report a protocol using a non-integrating Sendai virus vector for transduction of Yamanaka factors into urine cells collected from patients with muscular dystrophy, Abcam VIM antibody (Abcam, ab8978-100) was used in immunocytochemistry on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
Abcam VIM antibody (Abcam, ab8069) was used in immunocytochemistry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; fig 1
Abcam VIM antibody (Abcam, ab8069) was used in immunohistochemistry - paraffin section on human samples (fig 1). In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; rat
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on rat samples . Int J Mol Med (2014) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:200
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on human samples at 1:200. Acta Naturae (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:100; fig 7
In order to explore interactions between human tumor cells and a humanized bone microenvironment, Abcam VIM antibody (Abcam, ab8069) was used in immunohistochemistry on human samples at 1:100 (fig 7). Clin Exp Metastasis (2014) ncbi
mouse monoclonal (RV202)
  • western blot; human; fig 2A
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples (fig 2A). Prostate (2014) ncbi
mouse monoclonal (VI-10)
  • immunohistochemistry - paraffin section; mouse; 1:500
Abcam VIM antibody (Abcam, ab20346) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. Reproduction (2014) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - paraffin section; mouse
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry - paraffin section on mouse samples . Am J Pathol (2013) ncbi
mouse monoclonal (RV202)
  • western blot; human
In order to study the role of p63 in epithelial homeostasis and development, Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples . PLoS ONE (2013) ncbi
Invitrogen
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 2c
In order to investigate the effect off miR-509-5p and miR-1243 on gemcitabine efficacy in pancreatic cancer and its mechanism, Invitrogen VIM antibody (Thermo Fisher, V9) was used in western blot on human samples (fig 2c). Sci Rep (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:2000; loading ...; fig 5a
In order to test if Dub3 contributes to Snail1 stability in cancer cells, Invitrogen VIM antibody (Neomarkers, Ab-2) was used in western blot on human samples at 1:2000 (fig 5a). Nat Commun (2017) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; pig; loading ...
In order to generate an enzymatic approach to isolate highly purified populations of porcine aortic endothelial and smooth muscle cells, Invitrogen VIM antibody (Thermo Fisher, MA5-11883) was used in immunocytochemistry on pig samples . J Cell Physiol (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 2
In order to characterize eight cases of renal cell carcinoma cases with NONO-TFE3, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Mod Pathol (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:100
In order to discuss the characteristics of Ewing's Sarcoma family of tumors of urinary bladder, Invitrogen VIM antibody (Thermo Scientific, V9) was used in immunohistochemistry on human samples at 1:100. Balkan Med J (2016) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:200; fig 1
In order to study the role of kif3a in dental mesenchymal stem and precursor cell differentiation, Invitrogen VIM antibody (Thermo Fisher, OMA1-06001) was used in immunocytochemistry on human samples at 1:200 (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; tbl 2
In order to characterize 21 cases of biphasic squamoid alveolar renal cell carcinoma, Invitrogen VIM antibody (NeoMarkers, D9) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 2). Am J Surg Pathol (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rat; 1:1000; loading ...; fig 7d
In order to use electroconducting microfibers to synergistically stimulate the proliferation and migration of glial progenitor cells, Invitrogen VIM antibody (Neomarkers, MS-129) was used in immunohistochemistry on rat samples at 1:1000 (fig 7d). Acta Biomater (2016) ncbi
mouse monoclonal (V9)
  • western blot; mouse; fig 2
In order to describe a technique to measure cell mechanotype, Invitrogen VIM antibody (Thermo Scientific, MS-129-PO) was used in western blot on mouse samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (RV203)
  • western blot; human; fig 7
In order to study ectosome-mediated trafficking in fibroblasts, Invitrogen VIM antibody (Thermo, RV203) was used in western blot on human samples (fig 7). Biochim Biophys Acta (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000
In order to test if urinary fluid shear stress alters the epithelial characteristics of the renal tubule, Invitrogen VIM antibody (Neomarkers, MS-129-P) was used in western blot on human samples at 1:1000. PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • western blot; human
In order to evaluate the effect of aspirin in mesenchymal to epithelial transition, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in western blot on human samples . Lab Invest (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:150
In order to describe a 40-year-old female patient with ovarian microcystic stromal tumor and familial adenomatous polyposis, Invitrogen VIM antibody (ZYMED, V9) was used in immunohistochemistry - paraffin section on human samples at 1:150. Genes Chromosomes Cancer (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; fig s6
In order to characterize evolutionarily conserved DNA architecture which determines target specificity of the TWIST family bHLH transcription factors, Invitrogen VIM antibody (Thermo Scientific, MS-129-P) was used in western blot on human samples (fig s6). Genes Dev (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:400
In order to study the effects of dental papilla-derived human dental pulp cells on osteogenic differentiation of human dental follicle cells, Invitrogen VIM antibody (Thermo Fisher Scientific, OMA1-06001) was used in immunocytochemistry on human samples at 1:400. J Mol Histol (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; rat; 1:50; fig 7g
In order to characterize a small population of Thy1(+) mesenchymal-epithelial cells present in rat liver., Invitrogen VIM antibody (Lab Vision Corporation, MS129-PO) was used in immunocytochemistry on rat samples at 1:50 (fig 7g). Am J Pathol (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Hum Pathol (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen VIM antibody (Thermo Fisher Scientific, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
Invitrogen VIM antibody (Thermo, V9) was used in immunocytochemistry on human samples . Eur J Cell Biol (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:200
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry on human samples at 1:200. Histopathology (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
In order to isolate and characterize PDGFR-beta(+) perivascular cells from infantile hemangioma, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in immunocytochemistry on human samples . Int J Clin Exp Pathol (2014) ncbi
mouse monoclonal (V9)
  • flow cytometry; human
Invitrogen VIM antibody (eBioscience, V9) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human
  • immunocytochemistry; human
  • western blot; human; 1:1000
Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry - paraffin section on human samples , in immunocytochemistry on human samples and in western blot on human samples at 1:1000. Br J Cancer (2014) ncbi
mouse monoclonal (V9)
  • western blot; mouse; fig 3
In order to determine the difference in apparent diffusion coefficient values between epithelial- and mesenchymal-like subcutaneous mouse xenografted tumors using diffusion-weighted magnetic resonance imaging, Invitrogen VIM antibody (Thermo Scientific, MS-129-P0) was used in western blot on mouse samples (fig 3). Int J Mol Sci (2013) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (V9)
  • western blot; human
In order to study the role of TWIST1 activation by the MMSET histone methyltransferase in driving epithelial-to-mesenchymal transition and invasiveness in prostate cancer, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in western blot on human samples . Oncogene (2013) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; fig 3
In order to assess the incidence and prognostic significance of the epithelial to mesenchymal transition in cancer of unknown primary, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry - paraffin section on human samples (fig 3). Anticancer Res (2012) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
In order to test if MSCs in hemangioma also reside in the perivascular region, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in immunocytochemistry on human samples . Pediatr Dev Pathol (2012) ncbi
mouse monoclonal (J144)
  • other; human; loading ...; tbl 5.1
In order to describe organelle-co-localized cell arrays, Invitrogen VIM antibody (ABR Affinity BioReagents, MA3-745) was used in other on human samples (tbl 5.1). Methods Mol Biol (2011) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:1000; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; pig; fig 7
In order to analyze the contributions of adipose tissue extract on wound healing, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on pig samples (fig 7). Wound Repair Regen (2007) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; dog; fig 2
  • western blot; human; fig 2
In order to study Goosecoid in human breast cells, Invitrogen VIM antibody (Neomarkers, MS129P) was used in immunohistochemistry on dog samples (fig 2) and in western blot on human samples (fig 2). Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:400
In order to perform a prospective study of epithelial-to-mesenchymal transition markers in biopsies obtained after engraftment from patients who received deceased donor kidneys and who had stable renal function, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry on human samples at 1:400. Am J Transplant (2006) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; rat; tbl 1
In order to characterize the tissue distribution of cytoskeletal proteins, cellular adhesion molecules, and proliferation markers in the follicular wall of letrozole-induced polycystic ovaries, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on rat samples (tbl 1). Arch Med Res (2006) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; rat
In order to compare the follicular structure and hormonal profiles of rats treated with the adrenocorticotrophic hormone with two experimental models of polycystic ovarian syndrome, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on rat samples . Physiol Res (2007) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry; human
In order to report on a case of soft tissue sacrococcygeal chordoma with intracytoplasmic filamentous inclusions, Invitrogen VIM antibody (Neomarkers, V9) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry on human samples . Pathol Res Pract (2005) ncbi
mouse monoclonal (V9)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen VIM antibody (Lab Vision, MS-129-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
Novus Biologicals
mouse monoclonal (RV202)
  • immunohistochemistry; mouse; loading ...; fig s2c
Novus Biologicals VIM antibody (Novus Biologicals, RV202) was used in immunohistochemistry on mouse samples (fig s2c). Diabetes (2017) ncbi
chicken polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 2k
In order to propose that Baf60c plays contributes to heart development and regeneration in young mice, Novus Biologicals VIM antibody (Novus Biologicals, NB300-223) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 2k). Dev Growth Differ (2016) ncbi
Sigma-Aldrich
mouse monoclonal (V9)
  • immunohistochemistry; domestic ferret; 1:200; loading ...; fig 11
Sigma-Aldrich VIM antibody (Sigma, V6389) was used in immunohistochemistry on domestic ferret samples at 1:200 (fig 11). J Comp Neurol (2019) ncbi
mouse monoclonal (V9)
  • western blot knockout validation; human; 1:100; loading ...; fig 4a
  • immunoprecipitation; human; loading ...; fig 1a
  • immunocytochemistry; human; 1:100; loading ...; fig 1b
Sigma-Aldrich VIM antibody (Sigma, V6389) was used in western blot knockout validation on human samples at 1:100 (fig 4a), in immunoprecipitation on human samples (fig 1a) and in immunocytochemistry on human samples at 1:100 (fig 1b). Biochem Biophys Res Commun (2018) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; loading ...; fig 3c
  • western blot; human; loading ...; fig 3d
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6389) was used in immunocytochemistry on human samples (fig 3c) and in western blot on human samples (fig 3d). Cell Death Differ (2019) ncbi
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 2a
Sigma-Aldrich VIM antibody (Sigma Life Sciences, V6389) was used in western blot on human samples (fig 2a). Oncogene (2018) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; 1:500; loading ...; fig 5b
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunocytochemistry on human samples at 1:500 (fig 5b). Nat Neurosci (2018) ncbi
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 1f
Sigma-Aldrich VIM antibody (Sigma, V9) was used in western blot on human samples (fig 1f). Genes Cells (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - frozen section; pig; loading ...; fig 9
In order to examine pathogenesis in Filial 1 progeny of a transgenic founder mini swine exhibiting severe Pro23His retinopathy, Sigma-Aldrich VIM antibody (Sigma, V 6630) was used in immunohistochemistry - frozen section on pig samples (fig 9). Transl Vis Sci Technol (2017) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; 1:50; loading ...; fig 1b
In order to investigate the stromal extracellular matrix-mediated gene expression and the associated phenotypic response, Sigma-Aldrich VIM antibody (Sigma, v6389) was used in immunocytochemistry on human samples at 1:50 (fig 1b). Sci Rep (2017) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; loading ...; fig 4
Sigma-Aldrich VIM antibody (Sigma, C9080) was used in immunocytochemistry on human samples (fig 4). Sci Rep (2017) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; 1:100; loading ...; fig s2b
Sigma-Aldrich VIM antibody (Sigma, V9) was used in immunocytochemistry on human samples at 1:100 (fig s2b). J Cell Sci (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rabbit; 1:200; fig 12a
In order to develop and assess corneal stromal Self-Lifting Analogous Tissue Equivalents (SLATEs), Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunohistochemistry on rabbit samples at 1:200 (fig 12a). Biomaterials (2017) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig 2g
In order to describe the transdifferentiation of human dermal fibroblasts towards the cardiac cell lineage, Sigma-Aldrich VIM antibody (Sigma, C9080) was used in immunocytochemistry on human samples (fig 2g). Sci Rep (2017) ncbi
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 5f
In order to evaluate the effects of matrix stiffness on vessel growth and integrity during angiogenesis, Sigma-Aldrich VIM antibody (Sigma, V6389) was used in western blot on human samples (fig 5f). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:500; loading ...; fig 1b
Sigma-Aldrich VIM antibody (Sigma, V6389) was used in western blot on human samples at 1:500 (fig 1b). Cancer Sci (2017) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; African green monkey; loading ...; fig 3a
  • immunocytochemistry; human; loading ...; fig 4
In order to elucidate how cells handle and respond to misfolded Caveolin-1, Sigma-Aldrich VIM antibody (Sigma, V6389) was used in immunocytochemistry on African green monkey samples (fig 3a) and in immunocytochemistry on human samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rat; 1:200; loading ...; fig 1a
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunohistochemistry on rat samples at 1:200 (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - frozen section; rat; fig 1h
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunohistochemistry - frozen section on rat samples (fig 1h). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 7c
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 7c). EMBO Mol Med (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:500; loading ...; fig 1g
In order to synthesize de novo excitable human tissues and augment impaired action potential conduction, Sigma-Aldrich VIM antibody (Sigma, v6630) was used in immunohistochemistry on human samples at 1:500 (fig 1g). Nat Commun (2016) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; fig 2
Sigma-Aldrich VIM antibody (Sigma, V9) was used in western blot on human samples at 1:1000 (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (V9)
  • western blot; rat; loading ...; fig 4a
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in western blot on rat samples (fig 4a). Front Cell Neurosci (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; mouse; fig 1
In order to study neural N-glycomics and their epigenetic regulation, Sigma-Aldrich VIM antibody (Sigma, V9) was used in immunocytochemistry on mouse samples (fig 1). Proteomics (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 2
Sigma-Aldrich VIM antibody (sigma, V6389) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 2). J Exp Clin Cancer Res (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:200; fig 2
In order to discuss how injuries to the limbus affects stem cells, Sigma-Aldrich VIM antibody (Novocastra, V6630) was used in immunohistochemistry on human samples at 1:200 (fig 2). Stem Cell Res Ther (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; rat; 1:1000; fig 4
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunohistochemistry - paraffin section on rat samples at 1:1000 (fig 4). J Neuroinflammation (2016) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; loading ...; fig 2b
In order to test if cancer cell motility is altered by growth conditions, an active SCF/c-Kit pathway, or X-irradiation treatment, Sigma-Aldrich VIM antibody (Sigma, C-9080) was used in western blot on human samples at 1:1000 (fig 2b). Radiother Oncol (2016) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; fig 1
Sigma-Aldrich VIM antibody (Sigma, V-6630) was used in western blot on human samples at 1:1000 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (V9)
  • western blot; rat; fig 2b
In order to study how glucose and glutamate transporters are regulated by Ghrelin in hypothalamic astrocytes, Sigma-Aldrich VIM antibody (Sigma, V6389) was used in western blot on rat samples (fig 2b). Sci Rep (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; rat; 1:200; loading ...; fig 1i
In order to identify GABAergic signaling in the rat pineal gland, Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 1i). J Pineal Res (2016) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; fig 2
In order to research induction of epithelial-to-mesenchymal transition by Polo-like kinase 1 and promotion of epithelial cell motility by activating CRAF/ERK signaling, Sigma-Aldrich VIM antibody (Sigma, V6389) was used in western blot on human samples at 1:1000 (fig 2). elife (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; rat; 1:100; fig 5
In order to analyze regulation of neural progenitor cell differentiation by the miR-20-Rest-Wnt signaling axis, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on rat samples at 1:100 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; pig; 1:50; fig 3
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunocytochemistry on pig samples at 1:50 (fig 3). PLoS ONE (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:400; fig s1
In order to utilize ovarian cancer xenograft models to study dynamic modulation of phosphoprotein expression, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig s1). BMC Cancer (2016) ncbi
mouse monoclonal (V9)
  • western blot; mouse; 1:100; fig 2
In order to elucidate the favor of Smad-independent TGF-beta signaling that drives EMT in pancreatic ductal adenocarcinoma due to TAp73 loss, Sigma-Aldrich VIM antibody (Sigma, V6389) was used in western blot on mouse samples at 1:100 (fig 2). Cell Death Differ (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; rat; 1:100; loading ...; fig 5b
In order to describe a protocol to isolate rat Sertoli cells, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on rat samples at 1:100 (fig 5b). J Vis Exp (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; loading ...; fig 1d
In order to show that induced expression of MYOCD results in the conversion of human endothelial progenitor cells to induced smooth muscle cells, Sigma-Aldrich VIM antibody (Sigma, C9080) was used in immunocytochemistry on human samples (fig 1d). Biomaterials (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; mouse; 1:200; fig s2a,b
In order to study modulation of Nkx2.5 expression by participating in transcription factor complexes that interact with nkx2.5 after desmin enters the nucleus of cardiac stem cells, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on mouse samples at 1:200 (fig s2a,b). Biol Open (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig s1a
  • western blot; human; 1:1000; fig 2d
Sigma-Aldrich VIM antibody (Sigma Aldrich, V6389) was used in immunocytochemistry on human samples (fig s1a) and in western blot on human samples at 1:1000 (fig 2d). Sci Rep (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:50
In order to report the contribution of DYRK1A and DYRK1B in cancer stem cells, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunohistochemistry on human samples at 1:50. Nature (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; mouse; 1:500; fig 1
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunohistochemistry on mouse samples at 1:500 (fig 1). Respir Res (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; dog; 1:200; fig 1
  • immunocytochemistry; human; 1:200; fig 1
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on dog samples at 1:200 (fig 1) and in immunocytochemistry on human samples at 1:200 (fig 1). Stem Cells Int (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; cow; 1:500; fig 2
In order to isolate and characterize buffalo amniotic membrane-derived epithelial cells, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on cow samples at 1:500 (fig 2). Anim Biotechnol (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:100; fig 3
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6389) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; pig; fig 3
In order to elucidate mechanisms that regulate reprogramming of porcine primordial germ cells, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on pig samples (fig 3). Cell Tissue Res (2016) ncbi
mouse monoclonal (V9)
  • western blot; rat; fig 2
Sigma-Aldrich VIM antibody (Sigma, V6389) was used in western blot on rat samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; fig 3
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in western blot on human samples (fig 3). Mol Cancer (2015) ncbi
mouse monoclonal (V9)
  • western blot; rat; 1:1000; loading ...; tbl 1
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in western blot on rat samples at 1:1000 (tbl 1). PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - frozen section; rabbit; loading ...; fig 3c
In order to develop an approach for three-dimensional characterization of normal and infarcted cardiac tissue at the submicrometer scale, Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunohistochemistry - frozen section on rabbit samples (fig 3c). Ann Biomed Eng (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; 1:40; fig 2
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on human samples at 1:40 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; fig 4
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6389) was used in western blot on human samples at 1:1000 (fig 4). PLoS Med (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; rat; 1:5000
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunocytochemistry on rat samples at 1:5000. Eur J Neurosci (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V9) was used in immunocytochemistry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:200; fig 3
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunohistochemistry on human samples at 1:200 (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; water buffalo; 1:200; fig 6
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on water buffalo samples at 1:200 (fig 6). PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig 5
  • western blot; human; fig s6
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on human samples (fig 5) and in western blot on human samples (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunocytochemistry on human samples . Appl Microbiol Biotechnol (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 3b
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in western blot on human samples (fig 3b). PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; dog; 1:1600
Sigma-Aldrich VIM antibody (Sigma, V6389) was used in immunocytochemistry on dog samples at 1:1600. Vet J (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; fig 4
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6389) was used in western blot on human samples at 1:1000 (fig 4). Oncol Lett (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - free floating section; human; 1:200
Sigma-Aldrich VIM antibody (SIGMA, V6630) was used in immunohistochemistry - free floating section on human samples at 1:200. J Cell Physiol (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; sheep; 10 ug/ml; loading ...; fig 2
In order to study the reprogramming of ovine induced pluripotent stem cells, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on sheep samples at 10 ug/ml (fig 2). Cell Reprogram (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; fig 5
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in western blot on human samples (fig 5). Oncotarget (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
In order to discover regulatory networks from epigenomes of surface ectoderm-derived cell types, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; water buffalo; 1:500
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on water buffalo samples at 1:500. Reprod Fertil Dev (2016) ncbi
mouse monoclonal (V9)
  • western blot; human; fig 3
In order to discuss drugs that prevent the epithelial-mesenchymal transition, Sigma-Aldrich VIM antibody (Sigma, V6389) was used in western blot on human samples (fig 3). COPD (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:30
In order to investigate the role of CAR in pluripotency and tight junctions of human embryos and stem cells, Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6389) was used in immunohistochemistry on human samples at 1:30. Reproduction (2014) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; 1:300
In order to study the effect of radiation on the progeny of colorectal cancer cells, Sigma-Aldrich VIM antibody (Sigma-Aldrich, C9080) was used in immunocytochemistry on human samples at 1:300. J Cell Biochem (2014) ncbi
mouse monoclonal (V9)
  • western blot; human
In order to describe a new in vitro model to test the effect of an aligned fibrous environment on cancer cell morphology and behavior, Sigma-Aldrich VIM antibody (Sigma Aldrich, V6389) was used in western blot on human samples . Acta Biomater (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - frozen section; rat; 1:10000
In order to investigate the role of artemin and its receptor in bladder physiology and pathophysiology, Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunohistochemistry - frozen section on rat samples at 1:10000. J Comp Neurol (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:20000
Sigma-Aldrich VIM antibody (Sigma, V9) was used in immunohistochemistry - paraffin section on human samples at 1:20000. Biomed Res Int (2014) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; mouse; 1:100
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunocytochemistry on mouse samples at 1:100. Exp Eye Res (2014) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V9) was used in immunocytochemistry on human samples . Mol Cell Endocrinol (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rat
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunohistochemistry on rat samples . PLoS ONE (2014) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:2000; loading ...; fig st13
Sigma-Aldrich VIM antibody (Sigma, V6630) was used in western blot on human samples at 1:2000 (fig st13). Nat Cell Biol (2014) ncbi
mouse monoclonal (V9)
  • reverse phase protein lysate microarray; human; 1:500
In order to study the epithelial to mesenchymal transition in the bronchial epithelium of patients with COPD and smokers, Sigma-Aldrich VIM antibody (Sigma, V6389) was used in reverse phase protein lysate microarray on human samples at 1:500. Pulm Pharmacol Ther (2014) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
In order to study the biophysical properties of amyotrophic lateral sclerosis-linked mutations of Cu/Zn superoxide dismutase 1 in human cells, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on human samples . Genes Cells (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; pig; 1:100
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunohistochemistry on pig samples at 1:100. Zygote (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; rat; 1:100
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunohistochemistry - paraffin section on rat samples at 1:100. J Ocul Pharmacol Ther (2013) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rat; 1:100
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunohistochemistry on rat samples at 1:100. J Ocul Pharmacol Ther (2013) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig 2
In order to measure the expression of epithelial-to-mesenchymal transition-associated proteins in renal cell carcinoma and compared expression levels with clinical outcome, Sigma-Aldrich VIM antibody (Sigma, V6630) was used in immunocytochemistry on human samples (fig 2). PLoS ONE (2012) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rat; 1:200
Sigma-Aldrich VIM antibody (Sigma-Aldrich, V6630) was used in immunohistochemistry on rat samples at 1:200. J Comp Neurol (2007) ncbi
Developmental Studies Hybridoma Bank
mouse monoclonal (AMF-17b)
  • western blot; human; loading ...; fig 1b
Developmental Studies Hybridoma Bank VIM antibody (DSHB, AMF-17b) was used in western blot on human samples (fig 1b). Mol Carcinog (2015) ncbi
mouse monoclonal (AMF-17b)
  • immunohistochemistry; pig; 1:100
Developmental Studies Hybridoma Bank VIM antibody (Hybridoma bank, AMF-17b) was used in immunohistochemistry on pig samples at 1:100. PLoS ONE (2012) ncbi
Articles Reviewed
  1. Hutchinson E, Chatterjee M, Reyes L, Djankpa F, Valiant W, Dardzinski B, et al. The effect of Zika virus infection in the ferret. J Comp Neurol. 2019;527:1706-1719 pubmed publisher
  2. Jiu Y. Vimentin intermediate filaments function as a physical barrier during intracellular trafficking of caveolin-1. Biochem Biophys Res Commun. 2018;507:161-167 pubmed publisher
  3. Gut G, Herrmann M, Pelkmans L. Multiplexed protein maps link subcellular organization to cellular states. Science. 2018;361: pubmed publisher
  4. Zhu Y, Qu C, Hong X, Jia Y, Lin M, Luo Y, et al. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1. Cell Death Differ. 2019;26:306-320 pubmed publisher
  5. Rademaker G, Hennequière V, Brohée L, Nokin M, Lovinfosse P, Durieux F, et al. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene. 2018;37:4398-4412 pubmed publisher
  6. Johnson M, Sun X, Kodani A, Borges Monroy R, Girskis K, Ryu S, et al. Aspm knockout ferret reveals an evolutionary mechanism governing cerebral cortical size. Nature. 2018;556:370-375 pubmed publisher
  7. Zheng C, Wang J, Lin M, Zhang P, Liu L, Lin J, et al. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer. J Exp Clin Cancer Res. 2018;37:59 pubmed publisher
  8. Victor M, Richner M, Olsen H, Lee S, Monteys A, Ma C, et al. Striatal neurons directly converted from Huntington's disease patient fibroblasts recapitulate age-associated disease phenotypes. Nat Neurosci. 2018;21:341-352 pubmed publisher
  9. You S, Guan Y, Li W. Epithelial?mesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3. Mol Med Rep. 2017;: pubmed publisher
  10. Ise H, Yamasaki S, Sueyoshi K, Miura Y. Elucidation of GlcNAc-binding properties of type III intermediate filament proteins, using GlcNAc-bearing polymers. Genes Cells. 2017;22:900-917 pubmed publisher
  11. Luo W, Tan P, Rodriguez M, He L, Tan K, Zeng L, et al. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition. J Biol Chem. 2017;292:15525-15537 pubmed publisher
  12. Hiramoto H, Muramatsu T, Ichikawa D, Tanimoto K, Yasukawa S, Otsuji E, et al. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Sci Rep. 2017;7:4002 pubmed publisher
  13. Ji H, Xiong Y, Zhang E, Song W, Gao Z, Yao F, et al. Which has more stem-cell characteristics: Müller cells or Müller cells derived from in vivo culture in neurospheres?. Am J Transl Res. 2017;9:611-619 pubmed
  14. Scott P, de Castro J, DeMarco P, Ross J, Njoka J, Walters E, et al. Progression of Pro23His Retinopathy in a Miniature Swine Model of Retinitis Pigmentosa. Transl Vis Sci Technol. 2017;6:4 pubmed publisher
  15. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  16. Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, et al. Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. Nat Commun. 2017;8:14228 pubmed publisher
  17. Carey S, MARTIN K, Reinhart King C. Three-dimensional collagen matrix induces a mechanosensitive invasive epithelial phenotype. Sci Rep. 2017;7:42088 pubmed publisher
  18. Nita I, Hostettler K, Tamo L, Medová M, Bombaci G, Zhong J, et al. Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells. Sci Rep. 2017;7:41901 pubmed publisher
  19. Jiu Y, Peranen J, Schaible N, Cheng F, Eriksson J, Krishnan R, et al. Vimentin intermediate filaments control actin stress fiber assembly through GEF-H1 and RhoA. J Cell Sci. 2017;130:892-902 pubmed publisher
  20. Gouveia R, González Andrades E, Cardona J, González Gallardo C, Ionescu A, Garzon I, et al. Controlling the 3D architecture of Self-Lifting Auto-generated Tissue Equivalents (SLATEs) for optimized corneal graft composition and stability. Biomaterials. 2017;121:205-219 pubmed publisher
  21. Christoforou N, Chakraborty S, Kirkton R, Adler A, Addis R, Leong K. Core Transcription Factors, MicroRNAs, and Small Molecules Drive Transdifferentiation of Human Fibroblasts Towards The Cardiac Cell Lineage. Sci Rep. 2017;7:40285 pubmed publisher
  22. Beigi F, Patel M, Morales Garza M, Winebrenner C, Gobin A, Chau E, et al. Optimized method for isolating highly purified and functional porcine aortic endothelial and smooth muscle cells. J Cell Physiol. 2017;232:3139-3145 pubmed publisher
  23. Bordeleau F, Mason B, Lollis E, Mazzola M, Zanotelli M, Somasegar S, et al. Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl Acad Sci U S A. 2017;114:492-497 pubmed publisher
  24. Kusumoto H, Shintani Y, Kanzaki R, Kawamura T, Funaki S, Minami M, et al. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma. Cancer Sci. 2017;108:528-535 pubmed publisher
  25. Han X, Fang Z, Wang H, Jiao R, Zhou J, Fang N. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494. Biochem Biophys Res Commun. 2016;480:675-681 pubmed publisher
  26. Xia Q, Wang Z, Chen N, Gan H, Teng X, Shi S, et al. Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement. Mod Pathol. 2017;30:416-426 pubmed publisher
  27. Tiwari A, Copeland C, Han B, Hanson C, Raghunathan K, Kenworthy A. Caveolin-1 is an aggresome-inducing protein. Sci Rep. 2016;6:38681 pubmed publisher
  28. Chaudhury A, Cheema S, Fachini J, Kongchan N, Lu G, Simon L, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7:13362 pubmed publisher
  29. Ibañez Rodriguez M, Noctor S, Muñoz E. Cellular Basis of Pineal Gland Development: Emerging Role of Microglia as Phenotype Regulator. PLoS ONE. 2016;11:e0167063 pubmed publisher
  30. Chakraborty D, Cui W, Rosario G, Scott R, Dhakal P, Renaud S, et al. HIF-KDM3A-MMP12 regulatory circuit ensures trophoblast plasticity and placental adaptations to hypoxia. Proc Natl Acad Sci U S A. 2016;113:E7212-E7221 pubmed
  31. Benkafadar N, Menardo J, Bourien J, Nouvian R, François F, Decaudin D, et al. Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy. EMBO Mol Med. 2017;9:7-26 pubmed publisher
  32. Takai K, Le A, Weaver V, Werb Z. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget. 2016;7:82889-82901 pubmed publisher
  33. Nguyen H, Kirkton R, Bursac N. Engineering prokaryotic channels for control of mammalian tissue excitability. Nat Commun. 2016;7:13132 pubmed publisher
  34. Tonyali S, Yazici S, Yeşilırmak A, Ergen A. The Ewing's Sarcoma Family of Tumors of Urinary Bladder: A Case Report and Review of the Literature. Balkan Med J. 2016;33:462-6 pubmed publisher
  35. Deskin B, Lasky J, Zhuang Y, Shan B. Requirement of HDAC6 for activation of Notch1 by TGF-?1. Sci Rep. 2016;6:31086 pubmed publisher
  36. Portillo J, Lopez Corcino Y, Miao Y, Tang J, Sheibani N, Kern T, et al. CD40 in Retinal Müller Cells Induces P2X7-Dependent Cytokine Expression in Macrophages/Microglia in Diabetic Mice and Development of Early Experimental Diabetic Retinopathy. Diabetes. 2017;66:483-493 pubmed publisher
  37. Jiang S, Chen G, Feng L, Jiang Z, Yu M, Bao J, et al. Disruption of kif3a results in defective osteoblastic differentiation in dental mesenchymal stem/precursor cells via the Wnt signaling pathway. Mol Med Rep. 2016;14:1891-900 pubmed publisher
  38. He Z, Forest F, Gain P, Rageade D, Bernard A, Acquart S, et al. 3D map of the human corneal endothelial cell. Sci Rep. 2016;6:29047 pubmed publisher
  39. Bai H, Wang M, Foster T, Hu H, He H, Hashimoto T, et al. Pericardial patch venoplasty heals via attraction of venous progenitor cells. Physiol Rep. 2016;4: pubmed publisher
  40. Evrard S, Lecce L, Michelis K, Nomura Kitabayashi A, Pandey G, Purushothaman K, et al. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun. 2016;7:11853 pubmed publisher
  41. Cui L, Wang Y, Yu R, Li B, Xie S, Gao Y, et al. Jia-Shen decoction-medicated serum inhibits angiotensin-II induced cardiac fibroblast proliferation via the TGF-?1/Smad signaling pathway. Mol Med Rep. 2016;14:1610-6 pubmed publisher
  42. Villarreal A, Rosciszewski G, Murta V, Cadena V, Usach V, Dodes Traian M, et al. Isolation and Characterization of Ischemia-Derived Astrocytes (IDAs) with Ability to Transactivate Quiescent Astrocytes. Front Cell Neurosci. 2016;10:139 pubmed publisher
  43. Cerman E, Akkoç T, Eraslan M, Sahin O, Ozkara S, Vardar Aker F, et al. Retinal Electrophysiological Effects of Intravitreal Bone Marrow Derived Mesenchymal Stem Cells in Streptozotocin Induced Diabetic Rats. PLoS ONE. 2016;11:e0156495 pubmed publisher
  44. Kizuka Y, Nakano M, Miura Y, Taniguchi N. Epigenetic regulation of neural N-glycomics. Proteomics. 2016;16:2854-2863 pubmed publisher
  45. Lin S, Gou G, Hsia C, Ho C, Huang K, Wu Y, et al. Simulated Microgravity Disrupts Cytoskeleton Organization and Increases Apoptosis of Rat Neural Crest Stem Cells Via Upregulating CXCR4 Expression and RhoA-ROCK1-p38 MAPK-p53 Signaling. Stem Cells Dev. 2016;25:1172-93 pubmed publisher
  46. Kuang J, Li L, Guo L, Su Y, Wang Y, Xu Y, et al. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells. J Exp Clin Cancer Res. 2016;35:88 pubmed publisher
  47. Mathan J, Ismail S, McGhee J, McGhee C, Sherwin T. Sphere-forming cells from peripheral cornea demonstrate the ability to repopulate the ocular surface. Stem Cell Res Ther. 2016;7:81 pubmed publisher
  48. Granados Durán P, López Ávalos M, Hughes T, Johnson K, Morgan B, Tamburini P, et al. Complement system activation contributes to the ependymal damage induced by microbial neuraminidase. J Neuroinflammation. 2016;13:115 pubmed publisher
  49. Eberle F, Saulich M, Leinberger F, Seeger W, Engenhart Cabillic R, Dikomey E, et al. Cancer cell motility is affected through 3D cell culturing and SCF/c-Kit pathway but not by X-irradiation. Radiother Oncol. 2016;119:537-43 pubmed publisher
  50. Alaee M, Danesh G, Pasdar M. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53. PLoS ONE. 2016;11:e0154323 pubmed publisher
  51. Fu Q, Huang Y, Wang Z, Chen F, Huang D, Lu Y, et al. Proteome Profile and Quantitative Proteomic Analysis of Buffalo (Bubalusbubalis) Follicular Fluid during Follicle Development. Int J Mol Sci. 2016;17: pubmed publisher
  52. Roulois D, Deshayes S, Guilly M, Nader J, Liddell C, Robard M, et al. Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine. Oncotarget. 2016;7:34664-87 pubmed publisher
  53. Nakamura R, Koshiba Takeuchi K, Tsuchiya M, Kojima M, Miyazawa A, Ito K, et al. Expression analysis of Baf60c during heart regeneration in axolotls and neonatal mice. Dev Growth Differ. 2016;58:367-82 pubmed publisher
  54. Ren M, Du C, Herrero Acero E, Tang Schomer M, Ozkucur N. A biofidelic 3D culture model to study the development of brain cellular systems. Sci Rep. 2016;6:24953 pubmed publisher
  55. Fuente Martín E, García Cáceres C, Argente Arizón P, Diaz F, Granado M, Freire Regatillo A, et al. Ghrelin Regulates Glucose and Glutamate Transporters in Hypothalamic Astrocytes. Sci Rep. 2016;6:23673 pubmed publisher
  56. Yu H, Benitez S, Jung S, Farias Altamirano L, Kruse M, Seo J, et al. GABAergic signaling in the rat pineal gland. J Pineal Res. 2016;61:69-81 pubmed publisher
  57. Wu J, Ivanov A, Fisher P, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. elife. 2016;5: pubmed publisher
  58. Hes O, Condom Mundo E, Peckova K, Lopez J, Martinek P, Vanecek T, et al. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?. Am J Surg Pathol. 2016;40:664-75 pubmed publisher
  59. Salzman D, Nakamura K, Nallur S, Dookwah M, Metheetrairut C, Slack F, et al. miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage. Nat Commun. 2016;7:10954 pubmed publisher
  60. Cui Y, Han J, Xiao Z, Chen T, Wang B, Chen B, et al. The miR-20-Rest-Wnt signaling axis regulates neural progenitor cell differentiation. Sci Rep. 2016;6:23300 pubmed publisher
  61. Xue B, Li Y, He Y, Wei R, Sun R, Yin Z, et al. Porcine Pluripotent Stem Cells Derived from IVF Embryos Contribute to Chimeric Development In Vivo. PLoS ONE. 2016;11:e0151737 pubmed publisher
  62. Yin S, Fan Y, Zhang H, Zhao Z, Hao Y, Li J, et al. Differential TGF? pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. Nat Commun. 2016;7:11012 pubmed publisher
  63. Palermo G, Neri Q, Cozzubbo T, Cheung S, Pereira N, Rosenwaks Z. Shedding Light on the Nature of Seminal Round Cells. PLoS ONE. 2016;11:e0151640 pubmed publisher
  64. Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed publisher
  65. Thakur A, Nigri J, Lac S, Leca J, Bressy C, Berthezene P, et al. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death Differ. 2016;23:1358-70 pubmed publisher
  66. Bhushan S, Aslani F, Zhang Z, Sebastian T, Elsässer H, Klug J. Isolation of Sertoli Cells and Peritubular Cells from Rat Testes. J Vis Exp. 2016;:e53389 pubmed publisher
  67. Collazos Castro J, García Rama C, Alves Sampaio A. Glial progenitor cell migration promotes CNS axon growth on functionalized electroconducting microfibers. Acta Biomater. 2016;35:42-56 pubmed publisher
  68. Ji H, Atchison L, Chen Z, Chakraborty S, Jung Y, Truskey G, et al. Transdifferentiation of human endothelial progenitors into smooth muscle cells. Biomaterials. 2016;85:180-194 pubmed publisher
  69. Fuchs C, Gawlas S, Heher P, Nikouli S, Paar H, Ivankovic M, et al. Desmin enters the nucleus of cardiac stem cells and modulates Nkx2.5 expression by participating in transcription factor complexes that interact with the nkx2.5 gene. Biol Open. 2016;5:140-53 pubmed publisher
  70. Ke W, Chen C, Luo H, Tang J, Zhang Y, Gao W, et al. Histone Deacetylase 1 Regulates the Expression of Progesterone Receptor A During Human Parturition by Occupying the Progesterone Receptor A Promoter. Reprod Sci. 2016;23:955-64 pubmed publisher
  71. Chen Y, Statt S, Wu R, Chang H, Liao J, Wang C, et al. High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Sci Rep. 2016;6:18815 pubmed publisher
  72. Lee S, Frattini V, Bansal M, Castano A, Sherman D, Hutchinson K, et al. An ID2-dependent mechanism for VHL inactivation in cancer. Nature. 2016;529:172-7 pubmed publisher
  73. Blum W, Pecze L, Felley Bosco E, Schwaller B. Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration. Respir Res. 2015;16:153 pubmed publisher
  74. Silva M, Matheus W, Garcia P, Stopiglia R, Billis A, Ferreira U, et al. Characterization of reactive stroma in prostate cancer: involvement of growth factors, metalloproteinase matrix, sexual hormones receptors and prostatic stem cells. Int Braz J Urol. 2015;41:849-58 pubmed publisher
  75. Palazzolo G, Quattrocelli M, Toelen J, Dominici R, Anastasia L, Tettamenti G, et al. Cardiac Niche Influences the Direct Reprogramming of Canine Fibroblasts into Cardiomyocyte-Like Cells. Stem Cells Int. 2016;2016:4969430 pubmed publisher
  76. Ghosh K, Selokar N, Gahlawat S, Kumar D, Kumar P, Yadav P. Amnion Epithelial Cells of Buffalo (Bubalus Bubalis) Term Placenta Expressed Embryonic Stem Cells Markers and Differentiated into Cells of Neurogenic Lineage In Vitro. Anim Biotechnol. 2016;27:38-43 pubmed publisher
  77. Osorio L, Farfán N, Castellón E, Contreras H. SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells. Mol Med Rep. 2016;13:778-86 pubmed publisher
  78. Batchelder C, Martinez M, Tarantal A. Natural Scaffolds for Renal Differentiation of Human Embryonic Stem Cells for Kidney Tissue Engineering. PLoS ONE. 2015;10:e0143849 pubmed publisher
  79. Qi D, Kaur Gill N, Santiskulvong C, Sifuentes J, Dorigo O, Rao J, et al. Screening cell mechanotype by parallel microfiltration. Sci Rep. 2015;5:17595 pubmed publisher
  80. Zhang Y, Ma J, Li H, Lv J, Wei R, Cong Y, et al. bFGF signaling-mediated reprogramming of porcine primordial germ cells. Cell Tissue Res. 2016;364:429-41 pubmed publisher
  81. Eakins R, Walsh J, Randle L, Jenkins R, Schuppe Koistinen I, Rowe C, et al. Adaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome. Sci Rep. 2015;5:16423 pubmed publisher
  82. Bartscht T, Rosien B, Rades D, Kaufmann R, Biersack H, Lehnert H, et al. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action. Mol Cancer. 2015;14:199 pubmed publisher
  83. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  84. Pai P, Rachagani S, Lakshmanan I, Macha M, Sheinin Y, Smith L, et al. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Mol Oncol. 2016;10:224-39 pubmed publisher
  85. Abou Kheir W, Eid A, El Merahbi R, Assaf R, Daoud G. A Unique Expression of Keratin 14 in a Subset of Trophoblast Cells. PLoS ONE. 2015;10:e0139939 pubmed publisher
  86. Herold S, Kumar P, Wichert S, Kretzschmar B, Bähr M, Rossner M, et al. Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53. PLoS ONE. 2015;10:e0138852 pubmed publisher
  87. Seidel T, Edelmann J, Sachse F. Analyzing Remodeling of Cardiac Tissue: A Comprehensive Approach Based on Confocal Microscopy and 3D Reconstructions. Ann Biomed Eng. 2016;44:1436-1448 pubmed publisher
  88. Santi A, Caselli A, Ranaldi F, Paoli P, Mugnaioni C, Michelucci E, et al. Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth. Biochim Biophys Acta. 2015;1853:3211-23 pubmed publisher
  89. Oltolina F, Zamperone A, Colangelo D, Gregoletto L, Reano S, Pietronave S, et al. Human Cardiac Progenitor Spheroids Exhibit Enhanced Engraftment Potential. PLoS ONE. 2015;10:e0137999 pubmed publisher
  90. Maris P, Blomme A, Palacios A, Costanza B, Bellahcène A, Bianchi E, et al. Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Med. 2015;12:e1001871 pubmed publisher
  91. Garwood C, Ratcliffe L, Morgan S, Simpson J, Owens H, Vazquez Villaseñor I, et al. Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors. Mol Brain. 2015;8:51 pubmed publisher
  92. Hodde D, Gerardo Nava J, Wöhlk V, Weinandy S, Jockenhövel S, Kriebel A, et al. Characterisation of cell-substrate interactions between Schwann cells and three-dimensional fibrin hydrogels containing orientated nanofibre topographical cues. Eur J Neurosci. 2016;43:376-87 pubmed publisher
  93. Liang S, Marti T, Dorn P, Froment L, Hall S, Berezowska S, et al. Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer. Cell Death Dis. 2015;6:e1824 pubmed publisher
  94. Stutz C, Reinz E, Honegger A, Bulkescher J, Schweizer J, Zanier K, et al. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides. PLoS ONE. 2015;10:e0132339 pubmed publisher
  95. Maggiorani D, Dissard R, Belloy M, Saulnier Blache J, Casemayou A, Ducassé L, et al. Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells. PLoS ONE. 2015;10:e0131416 pubmed publisher
  96. Takenaka C, Miyajima H, Yoda Y, Imazato H, Yamamoto T, Gomi S, et al. Controlled Growth and the Maintenance of Human Pluripotent Stem Cells by Cultivation with Defined Medium on Extracellular Matrix-Coated Micropatterned Dishes. PLoS ONE. 2015;10:e0129855 pubmed publisher
  97. Mohapatra S, Sandhu A, Singh K, Singla S, Chauhan M, Manik R, et al. Establishment of Trophectoderm Cell Lines from Buffalo (Bubalus bubalis) Embryos of Different Sources and Examination of In Vitro Developmental Competence, Quality, Epigenetic Status and Gene Expression in Cloned Embryos Derived from Them. PLoS ONE. 2015;10:e0129235 pubmed publisher
  98. Cheng J, Yang H, Fang J, Ma L, Gong R, Wang P, et al. Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation. Nat Commun. 2015;6:7023 pubmed publisher
  99. Kitagawa T, Okita H, Baron B, Tokuda K, Nakamura M, Wang Y, et al. Mutant screening for oncogenes of Ewing's sarcoma using yeast. Appl Microbiol Biotechnol. 2015;99:6737-44 pubmed publisher
  100. Gago Fuentes R, Fernández Puente P, Megias D, Carpintero Fernández P, Mateos J, Acea B, et al. Proteomic Analysis of Connexin 43 Reveals Novel Interactors Related to Osteoarthritis. Mol Cell Proteomics. 2015;14:1831-45 pubmed publisher
  101. Ho F, Zhang W, Li Y, Chan B. Mechanoresponsive, omni-directional and local matrix-degrading actin protrusions in human mesenchymal stem cells microencapsulated in a 3D collagen matrix. Biomaterials. 2015;53:392-405 pubmed publisher
  102. Karbalaie K, Tanhaei S, Rabiei F, Kiani Esfahani A, Masoudi N, Nasr Esfahani M, et al. Stem cells from human exfoliated deciduous tooth exhibit stromal-derived inducing activity and lead to generation of neural crest cells from human embryonic stem cells. Cell J. 2015;17:37-48 pubmed
  103. Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee S. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest. 2015;95:702-17 pubmed publisher
  104. Lund K, Dembinski J, Solberg N, Urbanucci A, Mills I, Krauss S. Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment. PLoS ONE. 2015;10:e0123684 pubmed publisher
  105. Lee S, Koh Y, Roh H, Cha H, Kwon Y. Ovarian microcystic stromal tumor: A novel extracolonic tumor in familial adenomatous polyposis. Genes Chromosomes Cancer. 2015;54:353-60 pubmed publisher
  106. Yamada A, Aki T, Unuma K, Funakoshi T, Uemura K. Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells. PLoS ONE. 2015;10:e0120192 pubmed publisher
  107. Chen X, Liu X, Lang H, Zhang S, Luo Y, Zhang J. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line. PLoS ONE. 2015;10:e0121319 pubmed publisher
  108. Ma W, Na M, Tang C, Wang H, Lin Z. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways. Mol Med Rep. 2015;12:1050-8 pubmed publisher
  109. Chang A, Liu Y, Ayyanathan K, Benner C, Jiang Y, Prokop J, et al. An evolutionarily conserved DNA architecture determines target specificity of the TWIST family bHLH transcription factors. Genes Dev. 2015;29:603-16 pubmed publisher
  110. Lin Y, Yang Z, Xu A, Dong P, Huang Y, Liu H, et al. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway. Sci Rep. 2015;5:8997 pubmed publisher
  111. Liu M, Flanagan T, Lu C, French A, Argyle D, Corcoran B. Culture and characterisation of canine mitral valve interstitial and endothelial cells. Vet J. 2015;204:32-9 pubmed publisher
  112. Afzal M, Strande J. Generation of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells. J Vis Exp. 2015;:52032 pubmed publisher
  113. Wong E, Wong S, Chan C, Lam E, Ho L, Lau C, et al. TP53-induced glycolysis and apoptosis regulator promotes proliferation and invasiveness of nasopharyngeal carcinoma cells. Oncol Lett. 2015;9:569-574 pubmed
  114. Long P, Tighe S, Driscoll H, Fortner K, Viapiano M, Jaworski D. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest. J Cell Physiol. 2015;230:1929-43 pubmed publisher
  115. Tange S, Oktyabri D, Terashima M, Ishimura A, Suzuki T. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines. PLoS ONE. 2014;9:e115684 pubmed publisher
  116. Yao P, Kang D, Wang X, Lin R, Ye Z. Cell-density-dependent manifestation of partial characteristics for neuronal precursors in a newly established human gliosarcoma cell line. In Vitro Cell Dev Biol Anim. 2015;51:345-52 pubmed publisher
  117. Park S, Bae H, Park J. Osteogenic differentiation and gene expression profile of human dental follicle cells induced by human dental pulp cells. J Mol Histol. 2015;46:93-106 pubmed publisher
  118. German S, Campbell K, Thornton E, McLachlan G, Sweetman D, Alberio R. Ovine induced pluripotent stem cells are resistant to reprogramming after nuclear transfer. Cell Reprogram. 2015;17:19-27 pubmed publisher
  119. Xu M, Zhu C, Zhao X, Chen C, Zhang H, Yuan H, et al. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget. 2015;6:979-94 pubmed
  120. Liu D, Yovchev M, Zhang J, Alfieri A, Tchaikovskaya T, Laconi E, et al. Identification and characterization of mesenchymal-epithelial progenitor-like cells in normal and injured rat liver. Am J Pathol. 2015;185:110-28 pubmed publisher
  121. Lowdon R, Zhang B, Bilenky M, Mauro T, Li D, Gascard P, et al. Regulatory network decoded from epigenomes of surface ectoderm-derived cell types. Nat Commun. 2014;5:5442 pubmed publisher
  122. Saini M, Selokar N, Agrawal H, Singla S, Chauhan M, Manik R, et al. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic st. Reprod Fertil Dev. 2016;28:824-37 pubmed publisher
  123. Milara J, Peiró T, Serrano A, Artigues E, Aparicio J, Tenor H, et al. Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cells in vitro. COPD. 2015;12:320-31 pubmed publisher
  124. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  125. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  126. García E, Machesky L, Jones G, Antón I. WIP is necessary for matrix invasion by breast cancer cells. Eur J Cell Biol. 2014;93:413-23 pubmed publisher
  127. Krivega M, Geens M, Van de Velde H. CAR expression in human embryos and hESC illustrates its role in pluripotency and tight junctions. Reproduction. 2014;148:531-44 pubmed publisher
  128. Bastos L, de Marcondes P, de Freitas Junior J, Leve F, Mencalha A, de Souza W, et al. Progeny from irradiated colorectal cancer cells acquire an EMT-like phenotype and activate Wnt/?-catenin pathway. J Cell Biochem. 2014;115:2175-87 pubmed publisher
  129. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  130. McLane J, Rivet C, Gilbert R, Ligon L. A biomaterial model of tumor stromal microenvironment promotes mesenchymal morphology but not epithelial to mesenchymal transition in epithelial cells. Acta Biomater. 2014;10:4811-4821 pubmed publisher
  131. Forrest S, Osborne P, Keast J. Characterization of axons expressing the artemin receptor in the female rat urinary bladder: a comparison with other major neuronal populations. J Comp Neurol. 2014;522:3900-27 pubmed publisher
  132. Yuan S, Guo Y, Zhou X, Shen W, Chen H. PDGFR-? (+) perivascular cells from infantile hemangioma display the features of mesenchymal stem cells and show stronger adipogenic potential in vitro and in vivo. Int J Clin Exp Pathol. 2014;7:2861-70 pubmed
  133. Fenton S, Hutchens K, Denning M. Targeting Fyn in Ras-transformed cells induces F-actin to promote adherens junction-mediated cell-cell adhesion. Mol Carcinog. 2015;54:1181-93 pubmed publisher
  134. van Neerven S, Krings L, Haastert Talini K, Vogt M, Tolba R, Brook G, et al. Human Schwann cells seeded on a novel collagen-based microstructured nerve guide survive, proliferate, and modify neurite outgrowth. Biomed Res Int. 2014;2014:493823 pubmed publisher
  135. Morris K, Nofchissey R, Pinchuk I, Beswick E. Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers. PLoS ONE. 2014;9:e98656 pubmed publisher
  136. Kowtharapu B, Stahnke T, Wree A, Guthoff R, Stachs O. Corneal epithelial and neuronal interactions: role in wound healing. Exp Eye Res. 2014;125:53-61 pubmed publisher
  137. Yi X, Li X, Zhou Y, Ren S, Wan W, Feng G, et al. Hepatocyte growth factor regulates the TGF-?1-induced proliferation, differentiation and secretory function of cardiac fibroblasts. Int J Mol Med. 2014;34:381-90 pubmed publisher
  138. Muchkaeva I, Dashinimaev E, Artyuhov A, Myagkova E, Vorotelyak E, Yegorov Y, et al. Generation of iPS Cells from Human Hair Follice Dermal Papilla Cells. Acta Naturae. 2014;6:45-53 pubmed
  139. Kerdivel G, Boudot A, Habauzit D, Percevault F, Demay F, Pakdel F, et al. Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines. Mol Cell Endocrinol. 2014;390:34-44 pubmed publisher
  140. Codeluppi S, Fernández Zafra T, Sandor K, Kjell J, Liu Q, Abrams M, et al. Interleukin-6 secretion by astrocytes is dynamically regulated by PI3K-mTOR-calcium signaling. PLoS ONE. 2014;9:e92649 pubmed publisher
  141. Hwang W, Jiang J, Yang S, Huang T, Lan H, Teng H, et al. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol. 2014;16:268-80 pubmed publisher
  142. Milara J, Peiró T, Serrano A, Guijarro R, Zaragozá C, Tenor H, et al. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD. Pulm Pharmacol Ther. 2014;28:138-48 pubmed publisher
  143. Hesami P, Holzapfel B, Taubenberger A, Roudier M, Fazli L, Sieh S, et al. A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone. Clin Exp Metastasis. 2014;31:435-46 pubmed publisher
  144. Kitamura A, Inada N, Kubota H, Matsumoto G, Kinjo M, Morimoto R, et al. Dysregulation of the proteasome increases the toxicity of ALS-linked mutant SOD1. Genes Cells. 2014;19:209-24 pubmed publisher
  145. Bohonowych J, Hance M, Nolan K, DEFEE M, Parsons C, Isaacs J. Extracellular Hsp90 mediates an NF-?B dependent inflammatory stromal program: implications for the prostate tumor microenvironment. Prostate. 2014;74:395-407 pubmed publisher
  146. Yu Y, Xiao C, Tan L, Wang Q, Li X, Feng Y. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-? signalling. Br J Cancer. 2014;110:724-32 pubmed publisher
  147. Sun R, Lei L, Liu S, Xue B, Wang J, Wang J, et al. Morphological changes and germ layer formation in the porcine embryos from days 7-13 of development. Zygote. 2015;23:266-76 pubmed publisher
  148. Chen Y, Pan H, Tseng H, Chu H, Hung Y, Yen Y, et al. Differentiated epithelial- and mesenchymal-like phenotypes in subcutaneous mouse xenografts using diffusion weighted-magnetic resonance imaging. Int J Mol Sci. 2013;14:21943-59 pubmed publisher
  149. Zheng Q, Wang X, Wen Q, Zhang Y, Chen S, Zhang J, et al. Wt1 deficiency causes undifferentiated spermatogonia accumulation and meiotic progression disruption in neonatal mice. Reproduction. 2014;147:45-52 pubmed publisher
  150. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  151. Xu Y, Xu Y, Liao L, Zhou N, Theissen S, Liao X, et al. Inducible knockout of Twist1 in young and adult mice prolongs hair growth cycle and has mild effects on general health, supporting Twist1 as a preferential cancer target. Am J Pathol. 2013;183:1281-1292 pubmed publisher
  152. Olsen J, Oyan A, Rostad K, Hellem M, Liu J, Li L, et al. p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model. PLoS ONE. 2013;8:e62547 pubmed publisher
  153. Chao H, Chuang M, Liu J, Liu X, Ho L, Pan W, et al. Baicalein protects against retinal ischemia by antioxidation, antiapoptosis, downregulation of HIF-1?, VEGF, and MMP-9 and upregulation of HO-1. J Ocul Pharmacol Ther. 2013;29:539-49 pubmed publisher
  154. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  155. Rodriguez A, Allegrucci C, Alberio R. Modulation of pluripotency in the porcine embryo and iPS cells. PLoS ONE. 2012;7:e49079 pubmed publisher
  156. Liu X, Wu B, Pan W, Zhang X, Liu J, Chen M, et al. Resveratrol mitigates rat retinal ischemic injury: the roles of matrix metalloproteinase-9, inducible nitric oxide, and heme oxygenase-1. J Ocul Pharmacol Ther. 2013;29:33-40 pubmed publisher
  157. Ezponda T, Popovic R, Shah M, Martinez Garcia E, Zheng Y, Min D, et al. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene. 2013;32:2882-90 pubmed publisher
  158. Stoyianni A, Goussia A, Pentheroudakis G, Siozopoulou V, Ioachim E, Krikelis D, et al. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Anticancer Res. 2012;32:1273-81 pubmed
  159. O Mahony F, Faratian D, Varley J, Nanda J, Theodoulou M, Riddick A, et al. The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma. PLoS ONE. 2012;7:e31557 pubmed publisher
  160. Yuan S, Chen R, Shen W, Chen H, Zhou X. Mesenchymal stem cells in infantile hemangioma reside in the perivascular region. Pediatr Dev Pathol. 2012;15:5-12 pubmed publisher
  161. Hu Y, Janitz M. High-throughput subcellular protein localization using transfected-cell arrays. Subcellular protein localization using cell arrays. Methods Mol Biol. 2011;706:53-72 pubmed publisher
  162. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  163. Fu X, Fang L, Li H, Li X, Cheng B, Sheng Z. Adipose tissue extract enhances skin wound healing. Wound Repair Regen. 2007;15:540-8 pubmed
  164. Berglöf E, af Bjerkén S, Stromberg I. Glial influence on nerve fiber formation from rat ventral mesencephalic organotypic tissue cultures. J Comp Neurol. 2007;501:431-42 pubmed
  165. Hartwell K, Muir B, Reinhardt F, Carpenter A, Sgroi D, Weinberg R. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A. 2006;103:18969-74 pubmed
  166. Hertig A, Verine J, Mougenot B, Jouanneau C, Ouali N, Sebe P, et al. Risk factors for early epithelial to mesenchymal transition in renal grafts. Am J Transplant. 2006;6:2937-46 pubmed
  167. Baravalle C, Salvetti N, Mira G, Pezzone N, Ortega H. Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch Med Res. 2006;37:830-9 pubmed
  168. Baravalle C, Salvetti N, Mira G, Lorente J, Ortega H. The role of ACTH in the pathogenesis of polycystic ovarian syndrome in rats: hormonal profiles and ovarian morphology. Physiol Res. 2007;56:67-78 pubmed
  169. Guarino M, Ballabio G, Rubino B, Nebuloni M, Tosoni A. Soft tissue sacrococcygeal chordoma with intracytoplasmic filamentous inclusions. Pathol Res Pract. 2005;201:699-704 pubmed
  170. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed